Kalvista Pharmaceuticals, Inc.盘中异动早盘大幅上涨5.76%

自选股智能写手07-12

北京时间2024年07月12日21时32分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价大幅拉升5.76%。截至发稿，该股报13.22美元/股，成交量1.3121万股，换手率0.03%，振幅3.20%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.03百万美元，每股收益-0.84美元，毛利-207000.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2450535689?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-12 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2450535689","market":"us","top_or_hot":-1,"title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.76%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年07月12日21时32分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价大幅拉升5.76%。截至发稿，该股报13.22美元/股，成交量1.3121万股，换手率0.03%，振幅3.20%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.03百万美元，每股收益-0.84美元，毛利-207000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kalvista Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.76%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKalvista Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.76%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-12 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年07月12日21时32分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价大幅拉升5.76%。截至发稿，该股报13.22美元/股，成交量1.3121万股，换手率0.03%，振幅3.20%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.03百万美元，每股收益-0.84美元，毛利-207000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b","article_id":"2450535689","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2450535689","pubTimestamp":1720791121,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年07月12日21时32分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.76%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。消息层面，截至21时32分，《Needham维持KalVista Pharmaceuticals买入评级，下调目标价至32美元》资讯为影响Kalvista Pharmaceuticals, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","KALV":"Kalvista Pharmaceuticals Inc"},"translate_title":"Kalvista Pharmaceuticals, Inc. Intraday Change Jumped 5.76% in Morning Trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KALV":0.9},"content_text":"北京时间2024年07月12日21时32分，Kalvista Pharmaceuticals, Inc.（KALV.us）股票出现异动，股价大幅拉升5.76%。截至发稿，该股报13.22美元/股，成交量1.3121万股，换手率0.03%，振幅3.20%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.03百万美元，每股收益-0.84美元，毛利-207000.00美元，市盈率-3.77倍。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Zura Bio Limited C/Wts (To Pur Com)、Qualigen Therapeutics, Inc.、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为644.29%、73.93%、23.29%，振幅较大的相关个股有Zura Bio Limited C/Wts (To Pur Com)、Anew Medical Inc C/Wts 21/06/2029 (To Pur Com)、Qualigen Therapeutics, Inc.，振幅分别为20.00%、13.95%、11.64%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。 公司的产品组合包括针对遗传性血管性水肿和糖尿病性黄斑水肿的小分子血浆激肽释放酶抑制剂； 和口服血浆激肽释放酶抑制剂。 从地理上讲，它在美国整个地区都有业务。消息层面，截至21时32分，《Needham维持KalVista Pharmaceuticals(KALV.US)买入评级，下调目标价至32美元》资讯为影响Kalvista Pharmaceuticals, Inc.的重要信息。该信息摘要如下：Needham分析师Serge Belanger维持KalVista Pharmaceuticals 买入评级，并将目标价从35美元下调至32美元。根据TipRanks数据显示，该分析师近一年总胜率为41.4%，总平均回报率为0.2%。TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450535689"}

Kalvista Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.76%

精彩评论

Kalvista Pharmaceuticals, Inc.盘中异动早盘大幅上涨5.76%